Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on the Effects of Cladribine on Brain Cells in Patients with Multiple Sclerosis
FinlandStudy on the Safety and Effectiveness of TolDec and Immunotherapy for Patients with Relapsing-Remitting Multiple Sclerosis
SpainStudy Comparing Weekly Islatravir/Lenacapavir Regimen to Standard Care in HIV Patients with Controlled Viral Load
GermanyStudy on Dolutegravir and Lamivudine for Maintaining Viral Control in Children with HIV Aged 2 to Under 15 Years
SpainStudy on the Effects of IDP-122 Lotion for Children with Moderate to Severe Plaque Psoriasis
PolandStudy on the Effects of Brepocitinib and Prednisone for Adults with Active Non-Infectious Uveitis
AustriaStudy on the Safety and Effects of ORG-129 in Patients with Fibrostenotic Crohn's Disease
AustriaStudy on the Effects of High-Flow Oxygen Therapy in Patients with Interstitial Lung Disease During Exercise
SpainStudy on Rituximab for Patients with Generalized Myasthenia Gravis
ItalyStudy on Baricitinib for New-Onset Polymyalgia Rheumatica Patients to Reduce Steroid Use
AustriaStudy of Dupilumab's Effect on Airway Mucus in Adults with Severe Asthma
AustriaStudy on Omalizumab and Mepolizumab for Patients with Severe Allergic and Eosinophilic Asthma
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
